These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 16546530

  • 1. Renoprotective effects of renin-angiotensin-system inhibitors.
    Adler A, Stratton I, Shine B.
    Lancet; 2006 Mar 18; 367(9514):897-8; author reply 900-2. PubMed ID: 16546530
    [No Abstract] [Full Text] [Related]

  • 2. Renoprotective effects of renin-angiotensin-system inhibitors.
    Mann JF, Ritz E, Kunz R.
    Lancet; 2006 Mar 18; 367(9514):900; author reply 900-2. PubMed ID: 16546535
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.
    Tempelhof MW.
    South Med J; 2009 Dec 18; 102(12):1201-2. PubMed ID: 20016423
    [No Abstract] [Full Text] [Related]

  • 7. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P, Chábová VČ, Vernerová Z, Walkowska A, Kompanowska-Jezierska E, Sadowski J, Vaňourková Z, Husková Z, Opočenský M, Skaroupková P, Schejbalová S, Kramer HJ, Rakušan D, Malý J, Netuka I, Vaněčková I, Kopkan L, Cervenka L.
    Clin Exp Pharmacol Physiol; 2010 Dec 18; 37(12):1159-69. PubMed ID: 20880190
    [Abstract] [Full Text] [Related]

  • 8. The renoprotective effects of RAS inhibition: focus on prevention and treatment of chronic kidney disease.
    Weir MR.
    Postgrad Med; 2009 Jan 18; 121(1):96-103. PubMed ID: 19179817
    [Abstract] [Full Text] [Related]

  • 9. [Renin-angiotensin-aldosterone system].
    Suzuki H.
    Nihon Rinsho; 2004 Jun 18; 62 Suppl 6():153-6. PubMed ID: 15250285
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
    Barnas U, Mayer G.
    Wien Klin Wochenschr; 1995 Jun 18; 107(1):10-4. PubMed ID: 7871784
    [Abstract] [Full Text] [Related]

  • 12. Dual blockade of the renin-angiotensin system in chronic renal disease: to do or not to do.
    Nakao N, Seno H, Kasuga H, Toriyama T, Kawahara H.
    Clin Exp Nephrol; 2004 Sep 18; 8(3):183-7. PubMed ID: 15480894
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Toward better renoprotection: lessons from angiotensin receptor blockers.
    Miyata T, Takizawa S.
    Hemodial Int; 2007 Apr 18; 11(2):164-8. PubMed ID: 17403166
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Blocking the renin-angiotensin system in chronic kidney disease].
    Segura J.
    Nefrologia; 2004 Apr 18; 24 Suppl(6):101-12, 187-235. PubMed ID: 15696901
    [No Abstract] [Full Text] [Related]

  • 19. The Remission Clinic approach to halt the progression of kidney disease.
    Remission Clinic Task Force, Clinical Research Center "Aldo e Cele Daccò".
    J Nephrol; 2011 Apr 18; 24(3):274-81. PubMed ID: 21534237
    [Abstract] [Full Text] [Related]

  • 20. Renoprotective properties of angiotensin-converting enzyme inhibitors: proofs and limits?
    Esnault VL.
    Nephron; 2000 Jun 18; 85(2):183-4. PubMed ID: 10867528
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.